Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial | ANNALS OF ONCOLOGY |